DK0496160T3 - Syntetisk omdannelse af Bryostatin 2 til Bryostatin 1 - Google Patents

Syntetisk omdannelse af Bryostatin 2 til Bryostatin 1

Info

Publication number
DK0496160T3
DK0496160T3 DK91311568.9T DK91311568T DK0496160T3 DK 0496160 T3 DK0496160 T3 DK 0496160T3 DK 91311568 T DK91311568 T DK 91311568T DK 0496160 T3 DK0496160 T3 DK 0496160T3
Authority
DK
Denmark
Prior art keywords
bryostatin
synthetic conversion
synthetic
conversion
converted
Prior art date
Application number
DK91311568.9T
Other languages
Danish (da)
English (en)
Inventor
George R Pettit
Original Assignee
Univ Arizona State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona State filed Critical Univ Arizona State
Application granted granted Critical
Publication of DK0496160T3 publication Critical patent/DK0496160T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Auxiliary Devices For Music (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
DK91311568.9T 1990-12-31 1991-12-12 Syntetisk omdannelse af Bryostatin 2 til Bryostatin 1 DK0496160T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/636,212 US5072004A (en) 1990-12-31 1990-12-31 Synthetic conversion of bryostatin 2 into bryostatin 1

Publications (1)

Publication Number Publication Date
DK0496160T3 true DK0496160T3 (da) 1997-07-28

Family

ID=24550938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91311568.9T DK0496160T3 (da) 1990-12-31 1991-12-12 Syntetisk omdannelse af Bryostatin 2 til Bryostatin 1

Country Status (10)

Country Link
US (1) US5072004A (es)
EP (1) EP0496160B1 (es)
JP (1) JP3225318B2 (es)
AT (1) ATE152724T1 (es)
CA (1) CA2057441C (es)
DE (1) DE69126011T2 (es)
DK (1) DK0496160T3 (es)
ES (1) ES2103788T3 (es)
GR (1) GR3023990T3 (es)
MX (1) MX9102830A (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7256286B2 (en) * 1999-11-30 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Bryostatin analogues, synthetic methods and uses
WO2002087423A2 (en) * 2001-05-02 2002-11-07 Blanchette Rockefeller Neurosciences Institute Carbonic anhydrase activators for enhancing learning and memory
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
US20050065205A1 (en) * 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US20080004332A1 (en) * 2002-03-07 2008-01-03 Alkon Daniel L Methods for alzheimer's disease treatment and cognitive enhancement
TW201207390A (en) 2004-05-18 2012-02-16 Brni Neurosciences Inst Method for screening agent for antidepressant activity
WO2007016202A1 (en) * 2005-07-29 2007-02-08 Blanchette Rockefeller Neurosciences Institute Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory
US7754465B2 (en) * 2006-04-27 2010-07-13 James A Papp Decontamination of biological agents
US20080025961A1 (en) 2006-07-28 2008-01-31 Alkon Daniel L Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory
CA2864550C (en) 2007-02-09 2018-07-10 Blanchette Rockefeller Neurosciences Institute Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
CN101848726A (zh) 2007-02-09 2010-09-29 布朗歇特洛克菲勒神经科学研究所 苔藓抑素、苔藓抑素类似物和其它相关物质对头部创伤引起的记忆缺陷和脑损伤的疗效
WO2012006516A2 (en) 2010-07-08 2012-01-12 Alkon Daniel L Dag-type and indirect protein kinase c activators and anticoagulant for the treatment of stroke
CA2808660A1 (en) 2010-08-19 2012-02-23 Blanchette Rockefeller Neurosciences Institute Treatment of cognitive disorders associated with abnormal dendritic spines using pkc activators
EP3967299A1 (en) 2011-11-13 2022-03-16 Cognitive Research Enterprises, Inc. Pkc activators and combinations thereof
WO2016130969A1 (en) 2015-02-13 2016-08-18 George Robert Pettit Silstatin compounds
US20180217163A1 (en) 2015-05-11 2018-08-02 Daniel L. Alkon Treatment of neurodegenerative conditions using pkc activators after determining the presence of the apoe4 allele
WO2019094709A1 (en) 2017-11-09 2019-05-16 Pettit George R Betulastatin compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4560774A (en) * 1982-11-17 1985-12-24 Arizona State University Macrocyclic lactones
US4611066A (en) * 1984-08-10 1986-09-09 Arizona State University Bryostatins 4 to 8
US4833257A (en) * 1986-07-28 1989-05-23 Arizona Board Of Regents Compositions of matter and methods of using same

Also Published As

Publication number Publication date
JP3225318B2 (ja) 2001-11-05
GR3023990T3 (en) 1997-10-31
MX9102830A (es) 1992-06-01
CA2057441A1 (en) 1992-07-01
CA2057441C (en) 2002-06-11
DE69126011T2 (de) 1997-09-25
ATE152724T1 (de) 1997-05-15
ES2103788T3 (es) 1997-10-01
US5072004A (en) 1991-12-10
EP0496160A1 (en) 1992-07-29
EP0496160B1 (en) 1997-05-07
DE69126011D1 (de) 1997-06-12
JPH0867683A (ja) 1996-03-12

Similar Documents

Publication Publication Date Title
DK0496160T3 (da) Syntetisk omdannelse af Bryostatin 2 til Bryostatin 1
DE3763011D1 (de) Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.
DE69327398D1 (de) Thermoplastisches struktursystem
AR038427A2 (es) Compuestos 15-alquil-14-hidroxilo de marcfortina y parahercuamida
FR2574130B1 (fr) Generateur d'energie actionne par les vagues
IT1094134B (it) Procedimento e impianto per l'incenerimento di rifiuti domestici
DE3586578D1 (de) Verfahren zur herstellung von synthetischen calciumsilicaten und ihre verwendungen.
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
DE3684563D1 (de) Kristallinische gallophosphatzusammensetzungen.
MX164095B (es) Mejoras a composicion de desprendimiento sostenido de floruro
BE877702A (fr) Installation de recuperation d'energie
AU540524B2 (en) Mixtures of optical brighteners
DK353988A (da) Slaggeforbraendingsanlaeg
FR2608169B1 (fr) Module de culture de micro-organismes
ES2068980T3 (es) Procedimiento para la preparacion de diterciobutoxidiacetoxisilano.
TR199600434A1 (tr) Ikame edilmis 8-klorokinolin'lerin ikame edilmis 8-hidrosikinolin'lere cevrilmesi.
TR21738A (tr) Florafenoksibenzil esterler,bunlarin hazirlanmasi ve pestisid olarak kullanimi
FR2614680B1 (fr) Absorbeur-stockeur souple d'energie solaire
OA05911A (fr) Installation d'épuration.
MX9207565A (es) Hidroxilacion.
AU117158S (en) Wind chimes
JPS52132094A (en) Polyester ether polyols
JPS53124606A (en) Purification of albumin
SE8604979D0 (sv) "relip" = rehabilitering lett i position
JPS5396381A (en) Culture of fine algae